COMPOUNDS FOR THE TREATMENT OF DISEASES CAUSED BY OXALATE ACCUMULATION
申请人:UNIVERSIDAD DE GRANADA
公开号:US20200197418A1
公开(公告)日:2020-06-25
The present invention relates to the use of derivatives of salicylic acid for the treatment of diseases or conditions linked to GO and/or PRODH2 enzyme activity, in particular diseases linked to an excess of oxalate, and for the treatment of patients with renal insufficiency (uremia or azotaemia) receiving haemodialysis or peritoneal dialysis, in particular patients treated with ascorbic acid (vitamin C), which is metabolised to oxalate, or patients with fibromyalgia and vulvar pain.
Selectivity in the photo-Fenton and photocatalytic hydroxylation of biphenyl-4-carboxylic acid and derivatives (viz. 4-phenylsalicylic acid and 5-phenylsalicylic acid)
作者:Timothy Hathway、Deborah Lipman Chernyshov、William S. Jenks
DOI:10.1002/poc.1839
日期:2011.12
The selectivity of hydroxylation of the distal rings of 4‐phenylbenzoic acid, 4‐phenylsalicylic acid, and 5‐phenylsalicylic acid were determined using partial TiO2‐mediated photocatalytic degradation and photo‐Fenton conditions. This separation of the binding site from the phenyl group being hydroxylated allows a less‐biased evaluation. The hydroxylation regiochemistry behaves as qualitatively expected